International Consortium on Anti-Virals / Consortium International sur les Thérapies Antivirales

En FrançaisMediaContactHome

International Consortium on Anti-Virals (Logo)

World Health through Science / Science sans Frontières

Break
OurTrent Editor's Note:
This is a cached copy.
The original document should be available
>> here <<.

Combating Global Pandemics

A Public Symposium hosted by the International Consortium on Anti-Virals (ICAV). September 23rd 2005, 9:00 am – 6:30 pm, Gzowski College, Symons Campus, Trent University, Peterborough, Ontario, Canada.

Please consult the ICAV Symposium page for registration and additional information.

Break
Trent University, Peterborough, Ontario

ICAV’s Fall Symposium at Trent University in Peterborough, Ontario, September 23–25, 2005, brings together scientists, researchers, medical experts and government representatives from around the world.

Break

The Global Threat

Illustration: The Global Threat

Currently every country in the world is at risk. The emergence of new infectious diseases is an inevitable consequence of the increase in international travel, climate change and more intensive agricultural practices, among other factors (More ...).

Break

The World Health Organization Estimates:

  • The 1918-1919 influenza pandemic caused an estimated 40-50 million deaths world wide.
  • Epidemiological models from the CDC, Atlanta, USA project a pandemic is likely to result in 2 to 7.4 million deaths globally.
Break

Participation in ICAV

Map: International Participation

ICAV was launched with International participation through an agreement to collaborate with Vizier, with Institut Pasteur in France and with the Klenk and the Hilgenfeld Labs in Germany as well as with the Burton Lab at Scripps and Limin Li/Stanley Cohen in US (More ...).

The ICAV Solution

Coronavirus Illustration

Launched in 2004, ICAV’s goal is to discover, develop and deliver new therapeutic interventions for existing and emerging viral diseases around the globe (More ...).

Coronavirus illustration credit: Alex Reznichenko.

Break

The ICAV Platform

The ICAV Platform is targeting human functions essential for viral infectivity. Many viruses use the same host functions as part of their infectious cycle. Drugs that inhibit these functions therefore have the potential to work against newly emerging viruses that also use these functions (more ...).

Break

Ottawa to Give $250-Million in Global War on Diseases

Relief project targets Africa's AIDS crisis and other illnesses in the Third World

Brian Laghi
Friday September 9, 2005

Ottawa will put a $250-million down payment today on a new international aid strategy aimed at relieving Third World illness, including AIDS in Africa. (continue reading at Globe and Mail.com ...).